Cytophage Technologies (TSXV:CYTO) Accumulated Depreciation : C$-1.69 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Cytophage Technologies's quarterly accumulated depreciation declined from Sep. 2023 (C$-1.33 Mil) to Dec. 2023 (C$0.00 Mil) but then increased from Dec. 2023 (C$0.00 Mil) to Mar. 2024 (C$-1.69 Mil).

Cytophage Technologies's annual accumulated depreciation increased from Dec. 2021 (C$-0.63 Mil) to Dec. 2022 (C$-1.00 Mil) but then stayed the same from Dec. 2022 (C$-1.00 Mil) to Dec. 2023 (C$0.00 Mil).

Cytophage Technologies Accumulated Depreciation Historical Data

The historical data trend for Cytophage Technologies's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Accumulated Depreciation Chart

Cytophage Technologies Annual Data

Trend

Dec21

Dec22

Dec23

Accumulated Depreciation

-0.63

-1.00

Cytophage Technologies Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial			-1.00	-	-1.33	-	-1.69

Cytophage Technologies Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Cytophage Technologies Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytophage Technologies (TSXV:CYTO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.